Hyhlik-Dürr A, Bischoff M S, Peters A S, Attigah N, Geisbüsch P, Böckler D
Klinik für Gefäßchirurgie und Endovaskuläre Chirurgie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Deutschland,
Chirurg. 2013 Oct;84(10):881-8. doi: 10.1007/s00104-013-2486-z.
Open repair of para-anastomotic aneurysms (pAAA) after conventional aortoiliac repair is associated with a high perioperative mortality and morbidity. Endovascular treatment options have evolved over the last decade. The aim of this article is to demonstrate and review these endovascular strategies.
Between 01/2009 and 06/2012, a total of 12 patients received endovascular treatment for proximal (n = 7) or distal (n = 5) pAAA (n = 2 contained rupture). A retrospective analysis of these patients was performed. Median age was 71.5 years (range 55-87 years). The median time interval between primary operation and endovascular repair of the pAAA was 15 years (range 1-31 years) and median follow-up was 1.3 years (range 0 days - 3 years). Endovascular exclusion of the pAAA was achieved by implantation of an aortouniiliac endograft (n = 6), chimney graft (n = 1), fenestrated endograft (n = 2) and iliac extension (n = 3).
Technical success could be achieved in all patients and in-hospital mortality was 16.8 % (n = 2). No patient required a reintervention but during follow-up one additional patient died due to gastrointestinal bleeding. No primary or secondary type I/III endoleaks were observed.
Despite a not negligible mortality rate endovascular treatment of para-anastomotic aneurysms and anastomotic pseudoaneurysms appears to be a safe alternative for conventional open repair.
传统主髂动脉修复术后吻合口周围动脉瘤(pAAA)的开放修复与高围手术期死亡率和发病率相关。在过去十年中,血管内治疗选择不断发展。本文旨在展示和回顾这些血管内治疗策略。
2009年1月至2012年6月期间,共有12例患者接受了近端(n = 7)或远端(n = 5)pAAA(n = 2包含破裂)的血管内治疗。对这些患者进行了回顾性分析。中位年龄为71.5岁(范围55 - 87岁)。pAAA初次手术与血管内修复之间的中位时间间隔为15年(范围1 - 31年),中位随访时间为1.3年(范围0天 - 3年)。通过植入主动脉单髂动脉移植物(n = 6)、烟囱式移植物(n = 1)、开窗式移植物(n = 2)和髂动脉延长术(n = 3)实现pAAA的血管内排除。
所有患者均取得技术成功,住院死亡率为16.8%(n = 2)。无患者需要再次干预,但随访期间有1例患者因胃肠道出血死亡。未观察到原发性或继发性I/III型内漏。
尽管死亡率不可忽视,但血管内治疗吻合口周围动脉瘤和吻合口假性动脉瘤似乎是传统开放修复的一种安全替代方法。